Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210).

MLA

Ferreras, Cristina, et al. “Results of Phase 2 Randomized Multi-Center Study to Evaluate the Safety and Efficacy of Infusion of Memory T Cells as Adoptive Therapy in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pneumonia and/or Lymphopenia (RELEASE NCT04578210).” Cytotherapy, vol. 26, no. 1, Jan. 2024, pp. 25–35. EBSCOhost, https://doi.org/10.1016/j.jcyt.2023.10.002.

APA

Ferreras, C., Hernández-Blanco, C., Martín-Quirós, A., Al-Akioui-Sanz, K., Mora-Rillo, M., Ibáñez, F., Díaz-Almirón, M., Cano-Ochando, J., Lozano-Ojalvo, D., Jiménez-González, M., Goterris, R., Sánchez-Zapardiel, E., de Paz, R., Guerra-García, P., Queiruga-Parada, J., Molina, P., Briones, M. L., Ruz-Caracuel, B., Borobia, A. M., … Pérez-Martínez, A. (2024). Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210). Cytotherapy, 26(1), 25–35. https://doi.org/10.1016/j.jcyt.2023.10.002

Chicago

Ferreras, Cristina, Clara Hernández-Blanco, Alejandro Martín-Quirós, Karima Al-Akioui-Sanz, Marta Mora-Rillo, Fátima Ibáñez, Mariana Díaz-Almirón, et al. 2024. “Results of Phase 2 Randomized Multi-Center Study to Evaluate the Safety and Efficacy of Infusion of Memory T Cells as Adoptive Therapy in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pneumonia and/or Lymphopenia (RELEASE NCT04578210).” Cytotherapy 26 (1): 25–35. doi:10.1016/j.jcyt.2023.10.002.